Healthcare-associated infections at a children's cancer hospital, 1983-2008

Journal of the Pediatric Infectious Diseases Society

Volumn 1, Issue 1, 2012, Pages 26-34

  McCullers, Jonathan A ^a   Williams, Bonnie F ^a   Wu, Song ^a,b   Smeltzer, Matthew P ^a   Williams, Bobby G ^a,b   Hayden, Randall T ^a   Howard, Scott C ^a   Pui, Ching Hon ^a   Hughes, Walter T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Stony Brook University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOODSTREAM INFECTION; BONE MARROW TRANSPLANTATION; CANDIDA; ESCHERICHIA COLI; FUNGEMIA; GASTROINTESTINAL INFECTION; HEALTHCARE ASSOCIATED INFECTION; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MYCOSIS; NEOPLASM; NEUTROPENIA; NEUTROPHIL COUNT; PRIORITY JOURNAL; RISK FACTOR; SKIN INFECTION; STAPHYLOCOCCUS; SURGICAL INFECTION; URINARY TRACT INFECTION; VIRUS INFECTION;

EID: 84900400889     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pis034     Document Type: Article

References (21)

1. Simone JV. A history of St Jude Children's Research Hospital. Br J Haematol 2003; 120:549-55.
2. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360:2730-41.
3. Rubnitz JE, Inaba H, Dahl G, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol 2010; 11:543-52.
4. Bodey GP. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years. J Antimicrob Chemother 2009; 63(Suppl 1) :i3-13.
5. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating healthcare-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007; 122:160-66.
6. Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol 2009; 10:589-97.
7. Rotstein C, Cummings KM, Nicolaou AL, Lucey JFitzpatrick J. Nosocomial infection rates at an oncology center. Infect Control Hosp Epidemiol 1988; 9:13-19.
8. Robinson GV, Tegtmeier BR, Zaia JA. Brief report: nosocomial infection rates in a cancer treatment center. Infect Control 1984; 5:289-94.
9. Ford-Jones EL, MindorffCM, Langley JM, et al. Epidemiologic study of 4684 hospital-acquired infections in pediatric patients. Pediatr Infect Dis J 1989; 8: 668-75.
10. Simon A, Ammann RA, Bode U, et al. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 2008; 8:70.
11. Urrea M, Rives S, Cruz O, Navarro A, Garcia JJ, Estella J. Nosocomial infections among pediatric hematology/oncology patients: results of a prospective incidence study. Am J Infect Control 2004; 32:205-8.
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32.
13. Cardo D, Dennehy PH, Halverson P, et al. Moving toward elimination of healthcare-associated infections: a call to action. Infect Control Hosp Epidemiol 2010; 31:1101-5.
14. Schlesinger A, Paul M, Gafter-Gvili A, Rubinovitch B, Leibovici L. Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis. Lancet Infect Dis 2009; 9:97-107.
15. Castagnola E, Caviglia I, Pistorio A, et al. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer 2005; 41:1439-45.
16. van de Wetering MD, de Witte MA, Kremer LC, Offringa M, Scholten RJ, Caron HN. Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials. Eur J Cancer 2005; 41:1372-82.
17. Hughes WT. Bloodstream infections in cancer patients. Eur J Cancer 2005; 41:1370-1.
18. Hughes WT. Should prophylactic antibiotics be used in afebrile neutropenic oncology patients? Nat Clin Pract Oncol 2006; 3:130-1.
19. Hakim H, Gaur AH, McCullers JA. Motivating factors for high rates of influenza vaccination among healthcare workers. Vaccine 2011; 29:5963-9.
20. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.
21. Carlisle PS, Gucalp R, Wiernik PH. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993; 14:320-4.